Talking therapy may help seniors kick the benzodiazepine habit

NCT ID NCT06119308

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study tested a brief cognitive behavioral therapy (CBT) program designed to help older adults (55+) safely reduce or stop their use of benzodiazepines, which are commonly prescribed for insomnia and anxiety but can be risky with age. Seventeen participants received the therapy alongside a medication tapering plan over 10 weeks. The study measured how feasible and acceptable the program was, as well as changes in benzodiazepine use, sleep quality, and anxiety levels.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
cognitive behavioral therapy
What this could lead to
If successful, this approach could offer a practical, non-drug way to help older adults reduce their reliance on benzodiazepines for sleep and anxiety.
What could go wrong
This is a very small pilot study with only 17 participants and no comparison group, so results may not apply broadly. The intervention requires active participation and may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANXIETY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Beth Israel Deaconess Medical Center

    Boston, Massachusetts, 02215, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.